中国彝族人群幽门螺杆菌抗生素耐药性研究
该研究收集了501份彝族患者胃活检标本,分离出262株幽门螺杆菌(培养率52.3%),并进行了药敏试验。结果显示甲硝唑(86.3%)、利福平(52.7%)、左氧氟沙星(39.7%)和克拉霉素(22.9%)耐药率较高,而阿莫西林、四环素和呋喃唑酮耐药率极低。多药耐药率为32.1%,年龄和女性性别与部分抗生素耐药独立相关。
要点
- 彝族人群幽门螺杆菌对甲硝唑、利福平、左氧氟沙星和克拉霉素耐药率高,经验性用药应避免。
- 阿莫西林、四环素和呋喃唑酮耐药率极低,可作为治疗方案的有效选择。
- 该人群慢性萎缩性胃炎患病率高,需内镜筛查和及时根除幽门螺杆菌以预防胃癌。
核心结论
- 彝族患者中慢性萎缩性胃炎高发,应重视内镜筛查和及时根除幽门螺杆菌以预防胃癌。
- 由于耐药率高,克拉霉素、甲硝唑和左氧氟沙星不应作为经验性用药。
- 四环素、阿莫西林和呋喃唑酮耐药率极低,基于这些抗生素的治疗方案可能有效。
研究设计与样本
- 研究在中国2家医院接受内镜的彝族患者中收集胃活检标本,用于幽门螺杆菌分离和病理评估。
- 共从501份胃标本中分离出262株幽门螺杆菌,培养率为52.3%。
- 对阿莫西林、四环素、克拉霉素、甲硝唑、左氧氟沙星、利福平和呋喃唑酮进行药敏试验,采用Etest或纸片扩散法。
- 采用单因素和多因素 logistic 分析识别与抗菌药物耐药相关的因素。
主要发现
- 262例幽门螺杆菌阳性患者中,男性110例、女性152例,平均年龄40.7岁。
- 内镜表现:慢性萎缩性胃炎129例(49.2%)、消化性溃疡40例(15.3%)、胃恶性肿瘤2例(0.8%)。
- 病理分析显示中重度慢性胃萎缩患病率75.6%,肠化生14.7%,异型增生0.8%。
- 总体耐药率:阿莫西林0.0%、四环素0.4%、克拉霉素22.9%、甲硝唑86.3%、左氧氟沙星39.7%、利福平52.7%、呋喃唑酮0.0%。
- 多药耐药率为32.1%;年龄(对克拉霉素、甲硝唑和左氧氟沙星)和女性性别(对甲硝唑)是抗菌药物耐药的独立相关因素。
临床怎么用
- 在彝族幽门螺杆菌感染患者中,避免经验性使用克拉霉素、甲硝唑和左氧氟沙星。
- 可优先考虑基于阿莫西林、四环素或呋喃唑酮的治疗方案,但需结合个体情况。
- 对彝族患者应加强内镜筛查,及时发现慢性萎缩性胃炎并根除幽门螺杆菌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antibiotic resistance significantly impacts the success of Helicobacter pylori eradication. This study aimed to evaluate the antibiotic resistance patterns among a Chinese Yi ethnic population. METHODS: Gastric biopsy specimens were collected from Chinese Yi patients undergoing endoscopy at 2 hospitals for H. pylori isolation and pathological assessment. Antimicrobial susceptibility testing (AST) was performed for amoxicillin (AML), tetracycline (TET), clarithromycin (CLR), metronidazole (MTZ), levofloxacin (LEV), rifampicin (RIF), and furazolidone (FZD) using Etest or disk diffusion. Univariate and multivariate logistic analysis were used to identify factors associated with antimicrobial resistance. RESULTS: From 501 gastric specimens, 262 H. pylori strains were isolated (52.3% culture rate). Of the 262 H. pylori-positive patients (110 men and 152 women, mean age 40.7 years), endoscopic findings revealed that 129 (49.2%) had chronic atrophic gastritis, 40 (15.3%) had peptic ulcers, and 2 (0.8%) had gastric malignancy. Pathological analysis revealed a high prevalence of moderate-to-severe chronic gastric atrophy (75.6%), intestinal metaplasia (14.7%), and dysplasia (0.8%). The overall resistance rates were the following: AML (0.0%), TET (0.4%), CLR (22.9%), MTZ (86.3%), LEV (39.7%), RIF (52.7%), and FZD (0.0%). Multi-drug resistance was observed in 32.1% of the strains. Age (for CLR, MTZ, and LEV) and female gender (for MTZ) were independent factors associated with antimicrobial resistance. CONCLUSIONS: Chronic gastric atrophy is highly prevalent among Yi patients, emphasizing the need for endoscopic screening and prompt H. pylori eradication to prevent gastric cancer. Due to high resistance, CLR, MTZ, and LEV should not be used empirically. In contrast, TET, AML, and FZD show negligible resistance, treatment regimens based on these antibiotics are likely to be effective.
引用
- Zhang J, Wang Y, Chen L, et al. Antimicrobial Resistance of Helicobacter pylori Among Chinese Yi Population. J Infect Dis. 2025. PMID: 41264394. doi:10.1093/infdis/jiaf411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。